Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Autonomous growth potential of leukemia blast cells is associated with poor prognosis in human acute leukemias.

    Yan Y, Wieman EA, Guan X, Jakubowski AA, Steinherz PG, O'Reilly RJ.

    J Hematol Oncol. 2009 Dec 29;2:51.

    PMID:
    20040095
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Growth pattern and clinical correlation of subcutaneously inoculated human primary acute leukemias in severe combined immunodeficiency mice.

    Yan Y, Salomon O, McGuirk J, Dennig D, Fernandez J, Jagiello C, Nguyen H, Collins N, Steinherz P, O'Reilly RJ.

    Blood. 1996 Oct 15;88(8):3137-46.

    PMID:
    8874214
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Human t(1;19)(q23;p13) pre-B acute lymphoblastic leukemia in mice with severe combined immunodeficiency.

    Uckun FM, Downing JR, Gunther R, Chelstrom LM, Finnegan D, Land VJ, Borowitz MJ, Carroll AJ, Crist WM.

    Blood. 1993 Jun 1;81(11):3052-62.

    PMID:
    8098968
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Identification of variables determining the engraftment potential of human acute myeloid leukemia in the immunodeficient NOD/SCID human chimera model.

    Rombouts WJ, Martens AC, Ploemacher RE.

    Leukemia. 2000 May;14(5):889-97.

    PMID:
    10803522
    [PubMed - indexed for MEDLINE]
    5.

    Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.

    Uckun FM, Sather H, Reaman G, Shuster J, Land V, Trigg M, Gunther R, Chelstrom L, Bleyer A, Gaynon P, et al.

    Blood. 1995 Feb 15;85(4):873-8.

    PMID:
    7849309
    [PubMed - indexed for MEDLINE]
    Free Article
    6.

    The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.

    Cesano A, Hoxie JA, Lange B, Nowell PC, Bishop J, Santoli D.

    Oncogene. 1992 May;7(5):827-36.

    PMID:
    1570153
    [PubMed - indexed for MEDLINE]
    8.

    Propagation of human blastic myeloid leukemias in the SCID mouse.

    Sawyers CL, Gishizky ML, Quan S, Golde DW, Witte ON.

    Blood. 1992 Apr 15;79(8):2089-98.

    PMID:
    1562735
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Childhood acute myeloid leukemia in mice with severe combined immunodeficiency.

    Chelstrom LM, Gunther R, Simon J, Raimondi SC, Krance R, Crist WM, Uckun FM.

    Blood. 1994 Jul 1;84(1):20-6.

    PMID:
    8018918
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    11.

    Growth of human T-cell lineage acute leukemia in severe combined immunodeficiency (SCID) mice and non-obese diabetic SCID mice.

    Steele JP, Clutterbuck RD, Powles RL, Mitchell PL, Horton C, Morilla R, Catovsky D, Millar JL.

    Blood. 1997 Sep 1;90(5):2015-9.

    PMID:
    9292537
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Antileukemia activity of a natural killer cell line against human leukemias.

    Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J, O'Reilly RJ.

    Clin Cancer Res. 1998 Nov;4(11):2859-68.

    PMID:
    9829753
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Good engraftment of B-cell precursor ALL in NOD-SCID mice.

    Baersch G, Möllers T, Hötte A, Dockhorn-Dworniczak B, Rübe C, Ritter J, Jürgens H, Vormoor J.

    Klin Padiatr. 1997 Jul-Aug;209(4):178-85.

    PMID:
    9293448
    [PubMed - indexed for MEDLINE]
    14.

    Final Report on Carcinogens Background Document for Styrene.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.

    PMID:
    20737009
    [PubMed - as supplied by publisher]
    15.

    AC133 antigen as a prognostic factor in acute leukemia.

    Lee ST, Jang JH, Min YH, Hahn JS, Ko YW.

    Leuk Res. 2001 Sep;25(9):757-67.

    PMID:
    11489469
    [PubMed - indexed for MEDLINE]
    16.

    Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.

    McGuirk J, Yan Y, Childs B, Fernandez J, Barnett L, Jagiello C, Collins N, O'Reilly RJ.

    Bone Marrow Transplant. 1998 Aug;22(4):367-74.

    PMID:
    9722072
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Acute lymphoblastic leukemias from relapse engraft more rapidly in SCID mice.

    Palucka AK, Scuderi R, Porwit A, Jeha S, Gruber A, Björkholm M, Beran M, Pisa P.

    Leukemia. 1996 Mar;10(3):558-63.

    PMID:
    8642875
    [PubMed - indexed for MEDLINE]
    18.

    Two serologic markers to monitor the engraftment, growth, and treatment response of human leukemias in severe combined immunodeficient mice.

    Arguello F, Sterry JA, Zhao YZ, Alexander MR, Shoemaker RH, Cohen HJ.

    Blood. 1996 May 15;87(10):4325-32.

    PMID:
    8639792
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Human t(4;11)(q21;q23) acute lymphoblastic leukemia in mice with severe combined immunodeficiency.

    Uckun FM, Downing JR, Chelstrom LM, Gunther R, Ryan M, Simon J, Carroll AJ, Tuel-Ahlgren L, Crist WM.

    Blood. 1994 Aug 1;84(3):859-65.

    PMID:
    8043867
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.

    Uckun FM, Waurzyniak BJ, Sensel MG, Chelstrom L, Crotty ML, Gaynon PS, Reaman GH.

    Leuk Lymphoma. 1998 Jul;30(3-4):269-77.

    PMID:
    9713959
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk